Multiple Endocrine Neoplasia Type 1
"Multiple Endocrine Neoplasia Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).
| Descriptor ID |
D018761
|
| MeSH Number(s) |
C04.588.322.400.500 C04.651.600.500 C04.700.630.500 C16.320.700.630.500 C19.344.400.500
|
| Concept/Terms |
Multiple Endocrine Neoplasia Type 1- Multiple Endocrine Neoplasia Type 1
- Multiple Endocrine Neoplasia Type I
- Neoplasms, Multiple Endocrine Type I
- Multiple Endocrine Neoplasms Type 1
- Neoplasia, Multiple Endocrine Type 1
- Neoplasms, Multiple Endocrine Type 1
- Wermer Syndrome
|
Below are MeSH descriptors whose meaning is more general than "Multiple Endocrine Neoplasia Type 1".
Below are MeSH descriptors whose meaning is more specific than "Multiple Endocrine Neoplasia Type 1".
This graph shows the total number of publications written about "Multiple Endocrine Neoplasia Type 1" by people in this website by year, and whether "Multiple Endocrine Neoplasia Type 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multiple Endocrine Neoplasia Type 1" by people in Profiles.
-
Beyond the three P's: adrenal involvement in MEN1. Endocr Relat Cancer. 2024 Feb 01; 31(2).
-
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab. 2023 11 17; 108(12):3260-3271.
-
Beyond the "3 Ps": A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1. Front Endocrinol (Lausanne). 2022; 13:1029041.
-
Evaluation of risk factors, long-term outcomes, and immediate and delayed autotransplantation to minimize postsurgical hypoparathyroidism in multiple endocrine neoplasia type 1 (MEN1): A retrospective cohort study. Surgery. 2022 05; 171(5):1240-1246.
-
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab. 2021 11 19; 106(12):e4969-e4980.
-
Pancreas in Hereditary Syndromes: Cross-sectional Imaging Spectrum. Radiographics. 2021 Jul-Aug; 41(4):1082-1102.
-
It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 1. CA Cancer J Clin. 2021 09; 71(5):369-380.
-
Multiple Endocrine Neoplasia Type 1: Latest Insights. Endocr Rev. 2021 03 15; 42(2):133-170.
-
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives. Endocr Relat Cancer. 2020 08; 27(8):T9-T25.
-
Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies. Surgery. 2021 01; 169(1):175-184.